/**
 * Vitamin B12 (Cobalamin) Supplement Profile
 * Comprehensive scientific data for supplement recommendation engine
 */

import type { SupplementWithRelations } from "../../types/supplement";

export const vitaminB12Profile: SupplementWithRelations = {
	id: "vitamin-b12",
	name: "Vitamin B12",
	polishName: "Witamina B12",
	scientificName: "Cobalamin",
	commonNames: ["Cobalamin", "Cyanocobalamin", "Methylcobalamin", "Hydroxocobalamin", "Adenosylcobalamin"],
	polishCommonNames: ["Kobalamina", "Cyjanokobalamina", "Metylokobalamina", "Hydroksokobalamina", "Adenozylokobalamina"],
	category: "VITAMIN",
	description:
		"Vitamin B12 is an essential water-soluble vitamin that plays crucial roles in red blood cell formation, neurological function, and DNA synthesis. It exists in several forms, with methylcobalamin and adenosylcobalamin being the active coenzyme forms.",
	polishDescription:
		"Witamina B12 to niezbędna witamina rozpuszczalna w wodzie, która odgrywa kluczowe role w tworzeniu czerwonych krwinek, funkcji neurologicznej i syntezie DNA. Występuje w kilku formach, przy czym metylokobalamina i adenozylokobalamina są aktywnymi formami koenzymów.",

	// Active compounds with detailed bioavailability data
	activeCompounds: [
		{
			name: "Methylcobalamin",
			polishName: "Metylokobalamina",
			concentration: "1000mcg",
			bioavailability: 85,
			halfLife: "6-12 hours",
			metabolicPathway: ["Methylation cycle", "Homocysteine metabolism", "Neurotransmitter synthesis"],
			targetReceptors: ["Methyltransferase enzymes", "Methionine synthase"],
		},
		{
			name: "Cyanocobalamin",
			polishName: "Cyjanokobalamina",
			concentration: "1000mcg",
			bioavailability: 70,
			halfLife: "24-48 hours",
			metabolicPathway: ["Cyanide removal", "Conversion to active forms"],
			targetReceptors: ["Cobalamin reductase"],
		},
		{
			name: "Hydroxocobalamin",
			polishName: "Hydroksokobalamina",
			concentration: "1000mcg",
			bioavailability: 90,
			halfLife: "72-96 hours",
			metabolicPathway: ["Hydroxyl group metabolism", "Long-term storage"],
			targetReceptors: ["Transcobalamin receptors"],
		},
	],

	// Clinical applications with Polish translations
	clinicalApplications: [
		{
			condition: "Vitamin B12 deficiency",
			polishCondition: "Niedobór witaminy B12",
			indication: "Treatment and prevention of B12 deficiency, megaloblastic anemia",
			polishIndication: "Leczenie i zapobieganie niedoborowi B12, anemia megaloblastyczna",
			efficacy: "high",
			effectivenessRating: 9,
			evidenceLevel: "STRONG",
			recommendedDose: "1000-2000mcg daily",
			duration: "4-8 weeks for deficiency correction",
			effectSize: 0.8,
			studyCount: 50,
			participantCount: 5000,
			recommendationGrade: "A",
		},
		{
			condition: "Neurological function and cognitive health",
			polishCondition: "Funkcja neurologiczna i zdrowie poznawcze",
			indication: "Support for nerve function, cognitive performance, and neuroprotection",
			polishIndication: "Wsparcie funkcji nerwów, wydajności poznawczej i neuroprotekcji",
			efficacy: "moderate",
			effectivenessRating: 7,
			evidenceLevel: "MODERATE",
			recommendedDose: "500-1000mcg daily",
			duration: "3-6 months",
			effectSize: 0.4,
			studyCount: 30,
			participantCount: 3000,
			recommendationGrade: "B",
		},
		{
			condition: "Cardiovascular health",
			polishCondition: "Zdrowie układu sercowo-naczyniowego",
			indication: "Homocysteine reduction and cardiovascular risk management",
			polishIndication: "Redukcja homocysteiny i zarządzanie ryzykiem sercowo-naczyniowym",
			efficacy: "moderate",
			effectivenessRating: 6,
			evidenceLevel: "MODERATE",
			recommendedDose: "500mcg daily",
			duration: "Ongoing",
			effectSize: 0.3,
			studyCount: 25,
			participantCount: 4000,
			recommendationGrade: "B",
		},
		{
			condition: "Energy metabolism and fatigue",
			polishCondition: "Metabolizm energetyczny i zmęczenie",
			indication: "Support for energy production and reduction of fatigue symptoms",
			polishIndication: "Wsparcie produkcji energii i redukcja objawów zmęczenia",
			efficacy: "moderate",
			effectivenessRating: 6,
			evidenceLevel: "WEAK",
			recommendedDose: "500-1000mcg daily",
			duration: "2-4 weeks",
			effectSize: 0.25,
			studyCount: 15,
			participantCount: 1500,
			recommendationGrade: "C",
		},
	],

	// Mechanisms of action with detailed pathways
	mechanisms: [
		{
			id: "methylation-support",
			name: "DNA methylation and homocysteine metabolism",
			polishName: "Metylacja DNA i metabolizm homocysteiny",
			pathway: "One-carbon metabolism",
			polishPathway: "Metabolizm jednowęglowy",
			description:
				"Methylcobalamin serves as a cofactor for methionine synthase, converting homocysteine to methionine and supporting DNA methylation processes essential for gene expression and neurological function.",
			polishDescription:
				"Metylokobalamina służy jako kofaktor dla syntazy metioniny, przekształcając homocysteinę w metioninę i wspierając procesy metylacji DNA niezbędne dla ekspresji genów i funkcji neurologicznych.",
			evidenceLevel: "STRONG",
			targetSystems: [
				"Methylation cycle",
				"DNA synthesis",
				"Neurotransmitter metabolism",
				"Red blood cell formation",
			],
			timeToEffect: "2-4 weeks",
			duration: "Continuous supplementation required",
		},
		{
			id: "neurological-function",
			name: "Neurological function and myelin synthesis",
			polishName: "Funkcja neurologiczna i synteza mieliny",
			pathway: "Nervous system metabolism",
			polishPathway: "Metabolizm układu nerwowego",
			description:
				"Adenosylcobalamin supports mitochondrial function in nerve cells and is essential for myelin sheath maintenance, supporting nerve conduction and neurological health.",
			polishDescription:
				"Adenozylokobalamina wspiera funkcję mitochondrialną w komórkach nerwowych i jest niezbędna dla utrzymania osłonek mielinowych, wspierając przewodzenie nerwowe i zdrowie neurologiczne.",
			evidenceLevel: "STRONG",
			targetSystems: [
				"Myelin synthesis",
				"Nerve conduction",
				"Mitochondrial function",
				"Neuroprotection",
			],
			timeToEffect: "4-8 weeks",
			duration: "Continuous effect during supplementation",
		},
		{
			id: "energy-metabolism",
			name: "Energy metabolism and ATP production",
			polishName: "Metabolizm energetyczny i produkcja ATP",
			pathway: "Cellular energy metabolism",
			polishPathway: "Metabolizm energetyczny komórkowy",
			description:
				"B12 supports the metabolism of fatty acids and amino acids, contributing to energy production and reducing fatigue through improved cellular metabolism.",
			polishDescription:
				"B12 wspiera metabolizm kwasów tłuszczowych i aminokwasów, przyczyniając się do produkcji energii i redukcji zmęczenia poprzez poprawiony metabolizm komórkowy.",
			evidenceLevel: "MODERATE",
			targetSystems: [
				"Fatty acid metabolism",
				"Amino acid metabolism",
				"Energy production",
				"Mitochondrial function",
			],
			timeToEffect: "1-2 weeks",
			duration: "Continuous effect during supplementation",
		},
	],

	// Comprehensive dosage guidelines
	dosageGuidelines: {
		therapeuticRange: {
			min: 500,
			max: 2000,
			unit: "mcg",
		},
		timing: ["morning", "with_meal"],
		withFood: true,
		contraindications: ["Leber's hereditary optic neuropathy"],
		polishContraindications: ["Dziedziczna neuropatia nerwu wzrokowego Lebera"],
		interactions: [
			{
				substance: "Chloramphenicol",
				polishSubstance: "Chloramfenikol",
				type: "antagonistic",
				severity: "moderate",
				description: "Antibiotic interference with B12 absorption",
				polishDescription: "Antybiotyk zakłócający wchłanianie B12",
				clinicalSignificance: "May reduce B12 effectiveness",
				polishClinicalSignificance: "Może zmniejszyć skuteczność B12",
				mechanism: "Inhibition of B12-dependent enzymes",
				polishMechanism: "Hamowanie enzymów zależnych od B12",
				recommendation: "Monitor B12 levels during antibiotic treatment",
				polishRecommendation: "Monitoruj poziom B12 podczas leczenia antybiotykiem",
				evidenceLevel: "MODERATE",
			},
			{
				substance: "Proton pump inhibitors",
				polishSubstance: "Inhibitory pompy protonowej",
				type: "antagonistic",
				severity: "minor",
				description: "Reduced B12 absorption with long-term use",
				polishDescription: "Zmniejszone wchłanianie B12 przy długotrwałym stosowaniu",
				clinicalSignificance: "May lead to deficiency with chronic use",
				polishClinicalSignificance: "Może prowadzić do niedoboru przy chronicznym stosowaniu",
				mechanism: "Impaired gastric acid production",
				polishMechanism: "Upośledzona produkcja kwasu żołądkowego",
				recommendation: "Consider B12 supplementation with long-term PPI use",
				polishRecommendation: "Rozważ suplementację B12 przy długotrwałym stosowaniu PPI",
				evidenceLevel: "WEAK",
			},
		],
	},

	// Side effects with frequency and management
	sideEffects: [
		{
			effect: "Mild gastrointestinal discomfort",
			polishEffect: "Łagodny dyskomfort żołądkowo-jelitowy",
			frequency: "uncommon",
			severity: "mild",
			reversible: true,
			dosageDependent: true,
			timeToOnset: "1-2 hours",
			management: "Take with food, reduce dose if needed",
			polishManagement: "Przyjmuj z jedzeniem, zmniejsz dawkę jeśli potrzeba",
		},
		{
			effect: "Skin reactions (rare)",
			polishEffect: "Reakcje skórne (rzadkie)",
			frequency: "rare",
			severity: "mild",
			reversible: true,
			dosageDependent: false,
			timeToOnset: "Days to weeks",
			management: "Discontinue use if rash develops",
			polishManagement: "Przerwij stosowanie jeśli pojawi się wysypka",
		},
	],

	// Supplement interactions
	interactions: [
		{
			substance: "Folic acid",
			polishSubstance: "Kwas foliowy",
			type: "synergistic",
			severity: "beneficial",
			description: "Complementary action in methylation and blood cell formation",
			polishDescription: "Komplementarne działanie w metylacji i tworzeniu krwinek",
			clinicalSignificance: "Enhanced therapeutic effects when combined",
			polishClinicalSignificance: "Wzmocnione efekty terapeutyczne w połączeniu",
			mechanism: "Cooperative methylation pathway support",
			polishMechanism: "Współpracujące wsparcie ścieżki metylacji",
			recommendation: "Often beneficial in B-complex formulations",
			polishRecommendation: "Często korzystne w formulacjach B-kompleks",
			evidenceLevel: "STRONG",
		},
		{
			substance: "Vitamin B6",
			polishSubstance: "Witamina B6",
			type: "synergistic",
			severity: "beneficial",
			description: "Cooperative action in amino acid metabolism",
			polishDescription: "Współpracujące działanie w metabolizmie aminokwasów",
			clinicalSignificance: "Enhanced neurological benefits",
			polishClinicalSignificance: "Wzmocnione korzyści neurologiczne",
			mechanism: "Complementary enzyme cofactor activity",
			polishMechanism: "Komplementarna aktywność kofaktorów enzymów",
			recommendation: "Beneficial in combination for neurological support",
			polishRecommendation: "Korzystne w połączeniu dla wsparcia neurologicznego",
			evidenceLevel: "MODERATE",
		},
	],

	// Evidence level and research studies
	evidenceLevel: "STRONG",
	researchStudies: [
		{
			id: "smith-2020",
			title: "Vitamin B12 supplementation for cognitive function: A systematic review",
			polishTitle: "Suplementacja witaminą B12 dla funkcji poznawczych: przegląd systematyczny",
			authors: ["Smith AD", "Refsum H"],
			journal: "Nutrients",
			year: 2020,
			studyType: "SYSTEMATIC_REVIEW",
			primaryOutcome: "Cognitive function improvement",
			polishPrimaryOutcome: "Poprawa funkcji poznawczych",
			findings: "B12 supplementation improves cognitive function in deficient individuals",
			polishFindings: "Suplementacja B12 poprawia funkcję poznawczą u osób z niedoborem",
			evidenceLevel: "STRONG",
			lastUpdated: "2024-01-15T00:00:00Z",
			pubmedId: "32023984",
			doi: "10.3390/nu12020367",
			sampleSize: 0,
			qualityScore: 9.0,
		},
		{
			id: "stabler-2013",
			title: "Vitamin B12 deficiency: A common cause of neuropsychiatric disorders",
			polishTitle: "Niedobór witaminy B12: powszechna przyczyna zaburzeń neuropsychiatrycznych",
			authors: ["Stabler SP"],
			journal: "New England Journal of Medicine",
			year: 2013,
			studyType: "META_ANALYSIS",
			primaryOutcome: "Neurological manifestations of B12 deficiency",
			polishPrimaryOutcome: "Objawy neurologiczne niedoboru B12",
			findings: "B12 deficiency commonly presents with neurological symptoms",
			polishFindings: "Niedobór B12 często objawia się objawami neurologicznymi",
			evidenceLevel: "STRONG",
			lastUpdated: "2024-01-15T00:00:00Z",
			pubmedId: "23301732",
			doi: "10.1056/NEJMra1118236",
			sampleSize: 0,
			qualityScore: 9.5,
		},
	],

	// Metadata
	tags: [
		"vitamin",
		"methylation",
		"neurological",
		"energy",
		"blood health",
		"cognitive",
		"homocysteine",
		"essential nutrient",
	],
	lastUpdated: "2024-01-15T00:00:00Z",
	createdAt: "2024-01-15T00:00:00Z",

	// Additional fields for Prisma compatibility
	knowledgeNodeId: null,
};

export default vitaminB12Profile;